An Update on Epstein-Barr Virus and Nasopharyngeal Carcinogenesis

Head and Neck Pathology

Volumn 1, Issue 2, 2007, Pages 141-145

  Perez Ordoñez, Bayardo ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

RASSF1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN; VIRUS DNA;

CARCINOMA; CONFERENCE PAPER; EPSTEIN BARR VIRUS; GENE DELETION; GENE SILENCING; GENETICS; HUMAN; ISOLATION AND PURIFICATION; NASOPHARYNX TUMOR; PATHOLOGY; TUMOR SUPPRESSOR GENE; VIROLOGY;

CARCINOMA; DNA, VIRAL; GENE DELETION; GENE SILENCING; GENES, P16; HERPESVIRUS 4, HUMAN; HUMANS; NASOPHARYNGEAL NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 77957336339     PISSN: 1936055X     EISSN: 19360568     Source Type: Journal    
DOI: 10.1007/s12105-007-0020-7     Document Type: Article

References (37)

1. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004;4:757-68.
2. Sadler RH, Raab-Traub N. Structural analyses of the Epstein-Barr virus BamHI A transcripts. J Virol 1995;69:1132-41.
3. Chen A, Zhao B, Kieff E, Aster JC, Wang F. EBNA-3B-and EBNA-3C-regulated cellular genes in Epstein-Barr virusimmortalized lymphoblastoid cell lines. J Virol 2006;80:10139-50.
4. Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J Virol 1990;64:2309-18.
5. Mainou BA, Everly DN Jr, Raab-Traub N. Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K. Oncogene 2005;24:6917-24.
6. Mosialos G. Cytokine signaling and Epstein-Barr virus-mediated cell transformation. Cytokine Growth Factor Rev 2001;12:259-70.
7. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 1995;80:389-99.
8. Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol 2002;12:431-41.
9. Mainou BA, Raab-Traub N. LMP1 strain variants: biological and molecular properties. J Virol 2006;80:6458-68.
10. Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 1995;333:693-8.
11. Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986;47:883-9.
12. Gulley ML. Molecular diagnosis of Epstein-Barr virus-related diseases. J Mol Diagn 2001;3:1-10.
13. Lin JC, Wang WY, Chen KY, Wei YH, Liang WM, Jan JS, Jiang RS. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med 2004;350:2461-70.
14. Twu CW, Wang WY, Liang WM, Jan JS, Jiang RS, Chao J, Jin YT, Lin JC. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2007;67:130-7.
15. Makitie AA, Reis PP, Irish J, Zhang T, Chin SF, Chen X, Marriott C, Keller A, Perez-Ordonez B, Kamel-Reid S, Siu LL. Correlation of Epstein-Barr virus DNA in cell-free plasma, functional imaging and clinical course in locally advanced nasopharyngeal cancer: a pilot study. Head Neck 2004;26:815-22.
16. Chang KL, Chen YY, Shibata D, Weiss LM. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn Mol Pathol 1992;1:246-55.
17. Yeung WM, Zong YS, Chiu CT, Chan KH, Sham JS, Choy DT, Ng MH. Epstein-Barr virus carriage by nasopharyngeal carcinoma in situ. Int J Cancer 1993;53:746-50.
18. Pak MW, To KF, Lo YM, Chan LY, Tong JH, Lo KW, van Hasselt CA. Nasopharyngeal carcinoma in situ (NPCIS)-pathologic and clinical perspectives. Head Neck 2002;24:989-95.
19. Shih-Hsin WL. Construction of evolutionary tree models for nasopharyngeal carcinoma using comparative genomic hybridization data. Cancer Genet Cytogenet 2006;168:105-8.
20. Chan AS, To KF, Lo KW, Ding M, Li X, Johnson P, Huang DP. Frequent chromosome 9p losses in histologically normal nasopharyngeal epithelia from southern Chinese. Int J Cancer 2002;102:300-3.
21. Chan JKC, Bray F, McCarron P, Foo W, Lee AWM, Yip T, Kuo TT, Pilch BZ, Wenig BM, Huang D, Lo KW, Zeng YX, Jia WH. Nasopharyngeal carcinoma Barnes L, Eveson JW, Reichart P, Sidransky D World Health Organization Classification of Tumours. Pathology and Genetics. Head and Neck Tumours. 2005;85-97.
22. Pathmanathan R, Prasad U, Chandrika G, Sadler R, Flynn K, Raab-Traub N. Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia. Am J Pathol 1995;146:1355-67.
23. Tse LA, Yu IT, Mang OW, Wong SL. Incidence rate trends of histological subtypes of nasopharyngeal carcinoma in Hong Kong. Br J Cancer 2006;95:1269-73.
24. Lin HJ, Cherng JM, Hung MS, Sayion Y, Lin JC. Functional assays of HLA A2-restricted epitope variant of latent membrane protein 1 (LMP-1) of Epstein-Barr virus in nasopharyngeal carcinoma of Southern China and Taiwan. J Biomed Sci 2005;12:925-36.
25. Hu SP, Day NE, Li DR, Luben RN, Cai KL, Ou-Yang T, Li B, Lu XZ, Ponder BA. Further evidence for an HLA-related recessive mutation in nasopharyngeal carcinoma among the Chinese. Br J Cancer 2005;92:967-70.
26. Xiong W, Zeng ZY, Xia JH, Xia K, Shen SR, Li XL, Hu DX, Tan C, Xiang JJ, Zhou J, Deng H, Fan SQ, Li WF, Wang R, Zhou M, Zhu SG, Lu HB, Qian J, Zhang BC, Wang JR, Ma J, Xiao BY, Huang H, Zhang QH, Zhou YH, Luo XM, Zhou HD, Yang YX, Dai HP, Feng GY, Pan Q, Wu LQ, He L, Li GY. A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res 2004;64:1972-4.
27. Feng BJ, Huang W, Shugart YY, Lee MK, Zhang F, Xia JC, Wang HY, Huang TB, Jian SW, Huang P, Feng QS, Huang LX, Yu XJ, Li D, Chen LZ, Jia WH, Fang Y, Huang HM, Zhu JL, Liu XM, Zhao Y, Liu WQ, Deng MQ, Hu WH, Wu SX, Mo HY, Hong MF, King MC, Chen Z, Zeng YX. Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat Genet 2002;31:395-9.
28. Tiwawech D, Srivatanakul P, Karalak A, Ishida T. Glutathione Stransferase M1 gene polymorphism in Thai nasopharyngeal carcinoma. Asian Pac J Cancer Prev 2005;6:270-5.
29. Hildesheim A, Anderson LM, Chen CJ, Cheng YJ, Brinton LA, Daly AK, Reed CD, Chen IH, Caporaso NE, Hsu MM, Chen JY, Idle JR, Hoover RN, Yang CS, Chhabra SK. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 1997;89:1207-12.
30. Lo KW, Huang DP. Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin Cancer Biol 2002;12:451-62.
31. Lo KW, Huang DP, Lau KM. p16 gene alterations in nasopharyngeal carcinoma. Cancer Res 1995;55:2039-43.
32. Zhang Z, Sun D, Van do N, Tang A, Hu L, Huang G. Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma. Int J Cancer 2007;120:32-8.
33. Cheung F, Pang SW, Hioe F, Cheung KN, Lee A, Yau TK. Nasopharyngeal carcinoma in situ: two cases of an emerging diagnostic entity. Cancer 1998;83:1069-73.
34. Chow LS, Lo KW, Kwong J, To KF, Tsang KS, Lam CW, Dammann R, Huang DP. RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma. Int J Cancer 2004;109:839-47.
35. Zhou L, Jiang W, Ren C, Yin Z, Feng X, Liu W, Tao Q, Yao K. Frequent hypermethylation of RASSF1A and TSLC1, and high viral load of Epstein-Barr Virus DNA in nasopharyngeal carcinoma and matched tumor-adjacent tissues. Neoplasia 2005;7:809-15.
36. Kong WJ, Zhang S, Guo CK, Wang YJ, Chen X, Zhang SL, Zhang D, Liu Z, Kong W. Effect of methylation-associated silencing of the death-associated protein kinase gene on nasopharyngeal carcinoma. Anticancer Drugs 2006;17:251-9.
37. Shi W, Bastianutto C, Li A, Perez-Ordonez B, Ng R, Chow KY, Zhang W, Jurisica I, Lo KW, Bayley A, Kim J, O'Sullivan B, Siu L, Chen E, Liu FF. Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling. Int J Cancer 2006;119:2467-75.